Dermatologists spend remarkably little time on acne despite it affecting roughly 9.4% of the global population—making it one of the most common skin conditions worldwide. The disconnect between acne’s frequency and the attention it receives in dermatology practices stems from several converging factors: acne is clinically categorized as a benign condition that doesn’t threaten life, insurance reimbursement for acne treatment is often modest compared to procedures like Mohs surgery or injectables, and many dermatologists view acne as something that “naturally resolves” in most patients by their late twenties or early thirties. Yet for the individuals experiencing it—particularly teenagers and young adults—acne carries substantial psychological weight, impacts social relationships, and can leave lasting physical scars if not properly managed. This article explores why dermatology’s time allocation doesn’t match acne’s real burden on patients, how the condition is undervalued within medical systems, what barriers prevent more comprehensive acne care, and what patients can do when their dermatologist’s 10-minute appointment feels insufficient for the condition’s impact on their lives.
Table of Contents
- Why Is Acne Treated as Low-Priority Despite Affecting Millions?
- The Psychological and Social Burden That Medicine Overlooks
- Why Dermatologists Delegate Acne to Other Providers
- How Insurance Classification Limits Dermatology’s Investment in Acne
- The Reality of Treatment Complexity That Gets Rushed
- Acne Scars and Long-Term Consequences of Under-Treatment
- The Emerging Recognition and Changing Landscape
- Conclusion
Why Is Acne Treated as Low-Priority Despite Affecting Millions?
acne‘s classification as a “benign” condition is the primary reason dermatologists prioritize other diagnoses. While skin cancer requires immediate intervention to prevent mortality, and severe rosacea or psoriasis significantly impairs quality of life, acne is medically framed as temporary and self-limiting. In a typical dermatology practice, a 10-minute appointment for acne is standard, whereas a suspicious mole might receive 20 minutes and a skin cancer patient receives ongoing surgical or medical management. This time imbalance exists partly because acne doesn’t threaten physical health in the immediate term—it won’t metastasize or become life-threatening.
The financial incentive structure amplifies this neglect. Many insurance plans classify acne treatments as “cosmetic” rather than medical, limiting coverage for prescription medications and professional procedures. A dermatologist spending 30 minutes on a complex acne case might earn less in reimbursement than a 15-minute injection appointment for Botox or fillers (which are often paid out-of-pocket by patients). This creates an economic pressure toward high-turnover, lower-touch acne visits. Additionally, dermatologists in busy urban practices often have waiting lists extending months, making it economically rational to spend minimal time on each acne patient to maximize throughput.
The Psychological and Social Burden That Medicine Overlooks
The lived experience of acne bears little resemblance to medicine’s clinical minimization of it. research consistently shows that teenagers with moderate to severe acne report depression, anxiety, social withdrawal, and reduced academic or professional engagement at rates comparable to patients with asthma or diabetes. A 2018 study found that acne patients experience stress levels similar to those with serious chronic illnesses, yet dermatologists rarely spend time addressing this psychological component—screening for depression, discussing coping strategies, or connecting patients with mental health resources.
However, it’s important to recognize that the psychological impact varies significantly by individual and cultural context. A person with mild acne in a culture that normalizes skin imperfections may experience minimal distress, while another person with the same clinical severity in a different social environment might experience severe anxiety. This individual variation means that dermatologists cannot assume acne is “just cosmetic,” but it also means some patients benefit less from extended dermatology time than others. The missed opportunity is that dermatologists rarely take time to understand which category their patient falls into, instead defaulting to the assumption that acne is straightforward and quick to address.
Why Dermatologists Delegate Acne to Other Providers
Many dermatologists have begun outsourcing acne management to physician assistants, nurse practitioners, estheticians, and online telehealth providers. This delegation isn’t necessarily harmful—many PAs and NPs are highly trained in acne pathophysiology and treatment algorithms. However, it does reflect dermatology’s de-prioritization of acne as a condition worthy of specialist attention.
A top dermatologist in a major city might spend the majority of their time on cosmetic procedures, laser treatments, or surgical oncology, while acne care—which requires significant expertise in antibiotic selection, isotretinoin safety monitoring, hormonal treatment patterns, and scar revision—gets minimal focus. This creates a two-tiered system. Patients who can afford direct-to-consumer telehealth or dermatology concierge practices sometimes receive more acne time than those relying on insurance-covered visits, but they may also receive care from providers with less rigorous training. Dermatologists in rural areas or underserved communities often have little choice but to spend adequate time on acne simply because it comprises a larger portion of their patient load, revealing that the time-deprioritization is partly a luxury of high-demand practices in affluent areas.
How Insurance Classification Limits Dermatology’s Investment in Acne
Insurance companies classifying acne as “cosmetic” directly influences how dermatologists allocate time and resources. When a treatment isn’t covered or is only partially covered, patients often abandon care mid-course, and dermatologists face pressure from patients to offer cheaper alternatives or to justify why treatment costs are high. This creates a clinical spiral: dermatologists know patients can’t afford extended treatment plans, so they offer quick, cheaper fixes rather than comprehensive management, which in turn leads to treatment failure and patient dissatisfaction.
A specific example: isotretinoin (Accutane) is the only cure for severe acne, but it requires monthly office visits for lab monitoring, pregnancy prevention counseling for women, and regular dermatologist check-ins. Insurance often requires prior authorization and may deny coverage entirely, shifting the burden onto the patient. A dermatologist might spend 15 minutes with an isotretinoin candidate—not from lack of skill, but because the patient faces $5,000 in out-of-pocket costs and the dermatologist knows extensive counseling won’t change the insurance company’s decision. The time isn’t allocated because the system makes it economically punitive to do so.
The Reality of Treatment Complexity That Gets Rushed
Acne treatment is far more complex than the “quick prescription” model suggests. Effective acne management requires understanding someone’s skin type, hormonal status, lifestyle factors, medication interactions, and tolerance for side effects. A patient on oral contraceptives responds differently to retinoids than someone on no hormonal medication. Someone with oily, acne-prone skin tolerates different concentrations of benzoyl peroxide than someone with sensitive, dry-prone skin.
A teenager with mild inflammatory acne requires a different approach than a 35-year-old with hormonal cystic acne. Yet the standard appointment model doesn’t accommodate this complexity. A dermatologist might prescribe a topical retinoid, benzoyl peroxide wash, and oral doxycycline during a brief visit, without discussing retinization timelines (the 6-12 week adjustment period where skin may worsen before improving), without explaining why the patient shouldn’t use retinoids with vitamin C serums, and without warning that doxycycline increases sun sensitivity. Six weeks later, the patient has stopped treatment because their skin “got worse” or they experienced side effects they didn’t understand, and they conclude that dermatology “doesn’t work.” The appointment structure virtually guarantees treatment failure for a subset of patients—not because the prescriptions were wrong, but because the context and guidance were absent.
Acne Scars and Long-Term Consequences of Under-Treatment
One critical consequence of rushed acne care is scar formation. Severe acne that remains inadequately treated for months or years leads to permanent atrophic or hypertrophic scars—ice-pick scars, rolling scars, and boxcar scars that dermatologists can only partially improve through expensive procedures like microneedling, laser resurfacing, or subcision.
These scar treatments themselves receive more dermatology time and attention than the original acne prevention would have required, yet they’re often more difficult and less predictable. A patient who could have prevented scarring through appropriate oral antibiotics, retinoids, and dermatologist monitoring during their acne phase instead spends years (and thousands of dollars) trying to reverse the damage. From a medical efficiency standpoint, brief preventive acne appointments are a false economy—they lead to more complex, expensive, and time-intensive interventions later.
The Emerging Recognition and Changing Landscape
Some dermatologists and dermatology organizations are beginning to push back against the low-priority acne paradigm. Younger dermatologists, particularly those trained in the last decade, often advocate for dedicated acne clinics, extended appointment times for complex cases, and integrated mental health screening. Medical societies have started publishing guidelines acknowledging acne’s psychological impact and recommending comprehensive, patient-centered care.
Simultaneously, the rise of direct-to-consumer acne treatments—from prescription telehealth services to increasingly sophisticated over-the-counter retinoid formulations—is partially filling the gap that traditional dermatology left open. While not all of these services are equivalent to specialist care, their popularity reflects patient demand for more thorough acne guidance than the 10-minute appointment provides. Dermatology’s relationship with acne will likely continue evolving as both patient expectations and economic incentives shift.
Conclusion
Dermatologists spend less time on acne than its burden deserves primarily because medicine classifies it as benign and cosmetic, insurance reimbursement is low, and economic pressures in dermatology practices incentivize quick visits over comprehensive care. Meanwhile, acne patients—particularly young people—carry substantial psychological weight, risk permanent scarring from inadequate treatment, and often receive insufficient guidance to succeed with prescribed therapies.
This mismatch between clinical prioritization and lived impact represents a genuine gap in healthcare. If you’re experiencing acne and feel that your dermatology appointment didn’t adequately address your concerns, consider seeking a second opinion with a dermatologist or provider who specializes in acne, asking explicitly for more time or a follow-up appointment to discuss your treatment plan, or exploring telehealth services that offer extended acne consultations. You deserve care proportional to acne’s actual impact on your life—not just its classification in a medical textbook.
